These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Hassan A, Parisi JE, Josephs KA. Neurocase; 2012; 18(6):478-88. PubMed ID: 22181323 [Abstract] [Full Text] [Related]
23. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L. Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798 [Abstract] [Full Text] [Related]
26. Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al. (Brain-2004-01045.R1). Burn DJ. Brain; 2005 Jun; 128(Pt 6):1235-6. PubMed ID: 15900030 [No Abstract] [Full Text] [Related]
27. Progressive supranuclear palsy. Giagkou N, Höglinger GU, Stamelou M. Int Rev Neurobiol; 2019 Jun; 149():49-86. PubMed ID: 31779824 [Abstract] [Full Text] [Related]
28. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, Filippi M. Mov Disord; 2011 Feb 01; 26(2):247-55. PubMed ID: 21412831 [Abstract] [Full Text] [Related]
30. Midbrain/pons area ratio and clinical features predict the prognosis of progressive Supranuclear palsy. Cui SS, Ling HW, Du JJ, Lin YQ, Pan J, Zhou HY, Wang G, Wang Y, Xiao Q, Liu J, Tan YY, Chen SD. BMC Neurol; 2020 Mar 30; 20(1):114. PubMed ID: 32228519 [Abstract] [Full Text] [Related]
32. [A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy]. Yoshiike T, Ueda S, Takahashi M, Suda K, Furuta K, Koyama K. Seishin Shinkeigaku Zasshi; 2014 Mar 30; 116(5):359-69. PubMed ID: 24992742 [Abstract] [Full Text] [Related]
33. Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism. Agosta F, Pievani M, Svetel M, Ječmenica Lukić M, Copetti M, Tomić A, Scarale A, Longoni G, Comi G, Kostić VS, Filippi M. Neurobiol Aging; 2012 Dec 30; 33(12):2817-26. PubMed ID: 22418735 [Abstract] [Full Text] [Related]
34. Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): a short historical review. Pearce JM. Neurologist; 2007 Sep 30; 13(5):302-4. PubMed ID: 17848869 [Abstract] [Full Text] [Related]
36. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy. Sitek EJ, Konkel A, Dąbrowska M, Sławek J. Neurol Neurochir Pol; 2015 Sep 30; 49(1):36-40. PubMed ID: 25666771 [Abstract] [Full Text] [Related]
37. [Steele-Richardson-Olszewski syndrome]. Pletz C. Klin Monbl Augenheilkd; 2007 Dec 30; 224(12):939-42. PubMed ID: 18260059 [Abstract] [Full Text] [Related]
39. Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study. Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, Sugiyama H, Mori C, Inoue K, Fujimura H, Sawada H. PLoS One; 2015 Dec 30; 10(8):e0135823. PubMed ID: 26270456 [Abstract] [Full Text] [Related]
40. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools. Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D. Acta Neurol Scand; 2013 May 30; 127(5):362-70. PubMed ID: 23406296 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]